Alarm bells!

Recently, the Chongqing Food and Drug Administration released information on administrative law enforcement cases involving the production and sale of inferior drugs by a pharmaceutical company in Chongqing
.
According to the inspection by the Chongqing Wanzhou Food and Drug Inspection Institute, the "Liquiritin" in the [Content Determination] item of the pharmaceutical company did not meet the standard requirements and should be characterized as an inferior drug
.
At the same time, the company still failed to comply with the "Good Manufacturing Practice for Drugs"
.
According to relevant regulations, Chongqing Municipal Food and Drug Administration issued a warning to the enterprise, confiscate illegal property and confiscate illegal income
.
On March 2, the Hubei Provincial Food and Drug Administration released an administrative punishment information, and four pharmaceutical companies in Hubei were punished for producing and selling inferior drugs
.
The announcement shows that the drugs that these pharmaceutical companies failed to test involve Maren Pills, Ye Ning Granules, Yuanhu Pain Relief Tablets, and Passepartout.
The bureau has confiscated unqualified products, illegal gains and imposed fines on 4 companies.
wait for punishment
.
In February, the Fujian Provincial Food and Drug Administration issued an information disclosure form for administrative penalties, and publicized penalties for two pharmaceutical companies
.
One of them was fined 100,000 yuan for selling inferior medicine Qin Jiao
.
In addition, since the beginning of this year, many provincial food and drug administrations have announced the illegal behavior of pharmaceutical companies, involving many companies that have been punished by publicity for producing and selling inferior drugs.
Industry and a pharmaceutical company in Zhenjiang were punished for selling inferior drugs
.
Not only pharmaceutical companies, but also many pharmacies have been punished for selling inferior drugs this year
.
For example, it was reported on March 14 that a pharmacy in Pingyi County was fined 100,000 yuan by the Linyi Municipal Bureau of Supervision for purchasing drugs and selling inferior drugs from companies that did not have the qualifications for drug production and operation or the holders of drug marketing licenses
.
Drugs are special commodities, and the illegal behavior of pharmaceutical companies to sell inferior drugs will threaten the health of the people and harm the public interest
.
In recent years, relevant departments in China have actively organized and carried out supervision and inspection of pharmaceutical production and operation enterprises, and severely cracked down on illegal activities such as the production and sale of counterfeit and inferior drugs, so as to ensure the quality and safety of drugs
.
For the majority of pharmaceutical companies, under the background of stricter industry regulation, standardized operation is the long-term way
.
In particular, the implementation of the new version of the Drug Administration Law has greatly increased the illegal cost of enterprises
.
According to the new version of the "Drug Administration Law", the scope of counterfeit drugs includes: the ingredients contained in the drugs do not conform to the ingredients specified in the national drug standards; the non-drugs are passed off as drugs or other drugs are passed off as such drugs; spoiled drugs; Indications or functional indications are beyond the specified range
.
The scope of inferior drugs includes: the content of drug ingredients does not meet the national drug standards; contaminated drugs; drugs with no indication or change of expiry date; drugs with no indication or change of product batch number; drugs; other drugs that do not meet the drug standards
.
For the sale of fake and inferior drugs, according to the new version of the "Drug Administration Law", the minimum fine for selling counterfeit drugs is 1.
5 million yuan, and the minimum fine for retailing inferior drugs is 100,000 yuan
.
At present, many pharmaceutical companies have been fined millions of dollars for selling inferior drugs
.
The pharmaceutical industry's alarm bells have sounded
.
Under the increasingly strict drug supervision, the illegal cost of pharmaceutical companies will become higher and higher.
For the sake of long-term planning, companies need to strictly control all aspects of drug production
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.